Gelexir Healthcare


Gelexir Healthcare is a spin-out from the University of Manchester. They have developed a novel and proprietary injectable biomaterial technology for the treatment of chronic lower back pain caused by degenerative disc disease (DDD). The treatment, called Nucleus Pulposus Augmentation (NPA) consists of injecting the biomaterial in to the nucleus before the onset of irreversible disc degeneration of both the nucleus and annulus.